BPC-157 + TB-500 is the injectable blend combining two of the most widely researched tissue repair peptides
Pfizer's Acquisition of Hospira in 2015 Pfizer concluded its deal with Hospira in September 2015 for about $17 billion
Cause of Low B12 levels Pernicious anaemia vegan diet malabsorption syndromes coeliac sprue Crohn's ulcerative colitis (UC) "food-bound cobalamin malabsorption syndrome" predisposing factors include atrophic gastritis, long term proton pump inhibitor or H2 antagnoist use, chronic alcoholism, gastrectomy/gastric bypass surgery, pancreatic exocrine failure, AIDS myeloma (paraprotein related assay interference) pregnancy combined oral contraceptive pill/HRT pancreatric insufficiency metformin, acute phase situations
Shelf life: 24 months when stored correctly
The F-actin formation as detected by FITC-phalloidin staining was induced in BPC 157-treated fibroblasts
This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for consumption, self experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.